The Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Uric Acid in Type 2 Diabetes Mellitus.

Dong, Meiyuan; Chen, Huiling; Wen, Song; Yuan, Yue; Yang, Liling; Xu, Dongxiang; Zhou, Ligang

Dong, Meiyuan; Chen, Huiling; Wen, Song; Yuan, Yue; Yang, Liling; Xu, Dongxiang; Zhou, Ligang.

Affiliation

Dong M; Graduate School of Hebei Medical University, Shijiazhuang, People's Republic of China.
Chen H; Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People's Republic of China.
Wen S; Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People's Republic of China.
Yuan Y; Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People's Republic of China.
Yang L; Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People's Republic of China.
Xu D; Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People's Republic of China.
Zhou L; Department of Endocrinology, Shanghai Pudong Hospital, Fudan University, Shanghai, People's Republic of China.

Diabetes Metab Syndr Obes ; 16: 437-445, 2023.

Article de En | MEDLINE | ID: mdl-36820272

Mots clés

hyperuricemia; sodium-glucose cotransporter 2 inhibitors; type 2 diabetes mellitus; uric acid

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: Diabetes Metab Syndr Obes Année: 2023 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google